- MicroRNA Arrays,
- Next Gen Sequencing,
- Immunoassay,
- PCR-Based Assay
MicroRNA market size was valued at USD 440 million in 2023 and is poised to grow at a CAGR of 26.1% from 2024 to 2030. The inception of microRNA (miRNA) diagnostics in clinics has hastened the developments in precision medicine in cancer treatment. In addition, microRNAs are ideal postulants for noninvasive biomarkers in tumors due to many cells secreting miRNA identified in various body fluids. MicroRNA, with its roles in gene regulation and disease pathways, creates a substantial market demand, which in turn drives the growth of the market. A combination of factors, such as gene regulation, noninvasive biomarkers in cancer treatment, epigenetic modification, and biogenesis machinery, is driving the global miRNA market.
Additionally, the rise in Research Use efforts focused on addressing unmet medical needs in tumors is strengthening market growth. Collaborations between academic institutions, market players, and regulatory authorities aid knowledge sharing and accelerate miRNA market development. While comparing cells or tissues from young and old individuals, contrastingly expressed miRNA tends to be inarticulate in the latter; this suggests that the molecular pathway that regulates miRNA biogenesis is altered during aging and gene expression.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The rise in the prevalence of tumors/cancers worldwide is the primary market driver in the global microRNA market during the forecast period. Cancer affects the immune cells that carry immunity throughout the body. In November 2023, researchers at the American College of Surgeons, Chicago, stated that microRNA can be utilized in biomarkers to improve the long-term outcomes for patients with breast cancer. Moreover, R&D, technology innovation, disease association, and regulatory landscapes increase market acceptance.
The MicroRNA market size is expanded to be valued at USD 440 million.
The MicroRNA market is poised to grow at a significant CAGR of 26.1% from 2023 to 2030
Merck Kgaa, QIAGEN, Thermo Fisher Scientific Inc., Synlogic, Genecopoeia, Inc., Horizon Discovery Ltd., New England Bio labs, Quanta bio, Nanostring, Biogenex, Seqmatic LLC, Miltenyi Biotech, Agilent Technologies, Inc., Promega Corporation, Abcam Plc, KANEKA CORPORATION
1.Executive Summary |
2.Global Microrna Market Introduction |
2.1.Global Microrna Market - Taxonomy |
2.2.Global Microrna Market - Definitions |
2.2.1.Type |
2.2.2.Application |
2.2.3.End User |
2.2.4.Region |
3.Global Microrna Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Microrna Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Microrna Market By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. MicroRNA Arrays, |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Next Gen Sequencing, |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Immunoassay, |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. PCR-Based Assay |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Microrna Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Research and Development, |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Clinical Diagnostics |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Microrna Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Research and Academic Institutes, |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Biopharmaceutical Companies, |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Diagnostic Centers |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Microrna Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.MicroRNA Arrays, |
9.1.2.Next Gen Sequencing, |
9.1.3.Immunoassay, |
9.1.4.PCR-Based Assay |
9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Research and Development, |
9.2.2.Clinical Diagnostics |
9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Research and Academic Institutes, |
9.3.2.Biopharmaceutical Companies, |
9.3.3.Diagnostic Centers |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.MicroRNA Arrays, |
10.1.2.Next Gen Sequencing, |
10.1.3.Immunoassay, |
10.1.4.PCR-Based Assay |
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Research and Development, |
10.2.2.Clinical Diagnostics |
10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Research and Academic Institutes, |
10.3.2.Biopharmaceutical Companies, |
10.3.3.Diagnostic Centers |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
11.Asia Pacific (APAC) Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.MicroRNA Arrays, |
11.1.2.Next Gen Sequencing, |
11.1.3.Immunoassay, |
11.1.4.PCR-Based Assay |
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Research and Development, |
11.2.2.Clinical Diagnostics |
11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Research and Academic Institutes, |
11.3.2.Biopharmaceutical Companies, |
11.3.3.Diagnostic Centers |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.MicroRNA Arrays, |
12.1.2.Next Gen Sequencing, |
12.1.3.Immunoassay, |
12.1.4.PCR-Based Assay |
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Research and Development, |
12.2.2.Clinical Diagnostics |
12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Research and Academic Institutes, |
12.3.2.Biopharmaceutical Companies, |
12.3.3.Diagnostic Centers |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Microrna Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.MicroRNA Arrays, |
13.1.2.Next Gen Sequencing, |
13.1.3.Immunoassay, |
13.1.4.PCR-Based Assay |
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Research and Development, |
13.2.2.Clinical Diagnostics |
13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Research and Academic Institutes, |
13.3.2.Biopharmaceutical Companies, |
13.3.3.Diagnostic Centers |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Merck KGaA |
14.2.2.QIAGEN |
14.2.3.Thermo Fisher Scientific Inc. |
14.2.4.Synlogic |
14.2.5.GeneCopoeia, Inc. |
14.2.6.Horizon Discovery Ltd. |
14.2.7.New England Bio labs |
14.2.8.Quanta bio |
14.2.9.Nano String |
14.2.10.BioGenex |
14.2.11.SeqMatic LLC |
14.2.12.Miltenyi Biotech |
14.2.13.Agilent Technologies, Inc., |
14.2.14.Promega Corporation |
14.2.15.Abcam plc |
14.2.16.Kaneka Corporation |
15. Research Methodology |
16. Appendix and Abbreviations |